Alpha Omega has a leadership team highly experienced in clinical research.
leadership
Vlad Bogin, MD, FACP
CEO & Founder
Vlad is the founder and CEO of Alpha Omega. He trained at Yale and Brown Universities and received his postgraduate training at the University of Rochester, where he was also elected to a chief medical resident position. He has been involved in the drug development cycle for over 20 years, from basic discovery research to clinical trial design and execution. As a director at Boehringer Ingelheim, he led the late-stage development of a leading cardiology product.
MESSAGE FROM CEO
At Alpha Omega our philosophy is simple – our patients and clients come first. We strive to assist our partners in the advancement of their clinical development programs that improve the lives of our patients.
Since our establishment in 2004, we have fine-tuned our business model to reflect validated best practices from the most highly regulated venues, which we have carefully tailored to suit local environments. We are proud of our project managers, most with terminal medical degrees, because they not only adhere flawlessly to study protocols, but appreciate the science behind them.
At Alpha Omega we cannot think of a more rewarding job than that of accelerating development of new medicines that help improve and save patients’ lives. We have built an honest and hard-working CRO with a very simple philosophy – our social and business responsibility is to conduct ethical and high quality clinical trials while ensuring the safety of every patient and the integrity of medical data.
Vladimir Krechikov, MD, PhD
Head of region, Central & Eastern Europe
Vladimir started his career in clinical research as an Investigator, then worked at various operational roles at global CROs before transitioning to a Director of Business Development position at one of the largest regional CROs. He is Head of Region, Eastern Europe. He possesses a medical degree, received postgraduate training in Clinical Microbiology at Queen Mary University of London, and has a PhD in clinical pharmacology.
Vladimir Krechikov, MD, PhD
Head of region, Central & Eastern Europe
Vladimir started his career in clinical research as an Investigator, then worked at various operational roles at global CROs before transitioning to a Director of Business Development position at one of the largest regional CROs. He is Head of Region, Eastern Europe. He possesses a medical degree, received postgraduate training in Clinical Microbiology at Queen Mary University of London, and has a PhD in clinical pharmacology.